Medically reviewed by Daniel More, MD Many people with asthma as children go into long periods of remission, with infrequent ...

Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing inhaled therapeutics to treat serious respiratory ...

Poorly controlled asthma during pregnancy can lead to serious complications, such as low birth weight, preterm delivery, and ...

Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed strong safety and efficacy, with plans for a phase 2 trial in 2025.

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- A set of chameleon-like immune cells could be contributing to severe asthma in ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

A new treatment for severe dust mite allergy has been recommended by NICE, for patients whose symptoms have not been helped ...

Asthma biologics can be used during pregnancy to reduce the risk of complications associated with the disease. Apostolos ...

Scientists at Rutgers Health have made a groundbreaking discovery that could transform how asthma is diagnosed and monitored.